Development of a Novel [11C]CO-Labeled Positron Emission Tomography Radioligand [11C]BIO-1819578 for the Detection of O-GlcNAcase Enzyme Activity

Le résumé fourni par la source

High Resolution Image Download MS PowerPoint Slide Imaging O -GlcNAcase OGA by positron emission tomography (PET) could provide information on the pathophysiological pathway of neurodegenerative diseases and important information on drug-target engagement and be helpful in dose selection of therapeutic drugs. Our aim was to develop an efficient synthetic method for labeling BIO-1819578 with carbon-11 using 11 CO for evaluation of its potential to measure levels of OGA enzyme in non-human primate (NHP) brain using PET. Radiolabeling was achieved in one-pot via a carbon-11 carbonylation reaction using [ 11 C]CO. The detailed regional brain distribution of [ 11 C]BIO-1819578 binding was evaluated using PET measurements in NHPs. Brain radioactivity was measured for 93 min using a high-resolution PET system, and radiometabolites were measured in monkey plasma using gradient radio HPLC. Radiolabeling of [ 11 C]BIO-1819578 was successfully accomplished, and the product was found to be stable at 1 h after formulation. [ 11 C]BIO-1819578 was characterized in the cynomolgus monkey brain where a high brain uptake was found (7 SUV at 4 min). A pronounced pretreatment effect was found, indicating specific binding to OGA enzyme. Radiolabeling of [ 11 C]BIO-1819578 with [ 11 C]CO was successfully accomplished. [ 11 C]BIO-1819578 binds specifically to OGA enzyme. The results suggest that [ 11 C]BIO-1819578 is a potential radioligand for imaging and for measuring target engagement of OGA in the human brain.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.